» Authors » Menglin Chen

Menglin Chen

Explore the profile of Menglin Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 145
Citations 1002
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai D, Zhong G, Dai X, Zhao Z, Chen M, Hu J, et al.
Adv Sci (Weinh) . 2025 Feb; :e2411719. PMID: 39899681
Targeting cholesterol metabolism is a novel direction for tumor therapy. Unfortunately, the current use of statins for hepatocellular carcinoma (HCC) is controversial. Herein, farnesyl-diphosphate farnesyltransferase 1 (FDFT1) is identified as...
2.
Yuan J, Yang M, Wu Z, Wu J, Zheng K, Wang J, et al.
Adv Sci (Weinh) . 2025 Jan; e2414141. PMID: 39853940
Recipients often suffer from hyperlactatemia during liver transplantation (LT), but whether hyperlactatemia exacerbates hepatic ischemia-reperfusion injury (IRI) after donor liver implantation remains unclear. Here, the role of hyperlactatemia in hepatic...
3.
Li Z, Kovacs P, Friec A, Jensen B, Vinge Nygaard J, Chen M
Biofabrication . 2024 Oct; 17(1). PMID: 39437832
Mimicking the multilayered, anisotropic, elastic structure of cardiac tissues for controlled guidiance of 3D cellular orientation is essential in designing bionic scaffolds for cardiac tissue biofabrication. Here, a hierarchically organized,...
4.
Chen M, Zhao H, Tu H, Zhou J, He L
Hum Vaccin Immunother . 2024 Oct; 20(1):2411124. PMID: 39393042
No abstract available.
5.
Chen M, Zhao H, He L
J Surg Oncol . 2024 Sep; PMID: 39300895
No abstract available.
6.
Zeng Y, Wu Z, Chen G, Liu G, Zhang B, Zhou Y, et al.
Stem Cells Int . 2024 Jul; 2024:4654912. PMID: 39045027
Background: Using a toxin-induced lethal acute liver failure (ALF) monkey model, we have recently shown that early peripheral infusion of human umbilical cord mesenchymal stem cells (hUC-MSCs) can alleviate liver...
7.
Xu Q, Liu F, Wu Z, Chen M, Zhou Y, Shi Y
Biosci Trends . 2024 Jun; 18(3):289-302. PMID: 38925962
STK39 is reportedly a critical negative regulator of intestinal barrier. Pharmacological targeting of STK39 is expected to protect the intestinal barrier and thereby weaken metabolic dysfunction-associated steatohepatitis (MASH); Proximal colon...
8.
Zhang H, Yin F, Chen M, Qi A, Yang L, Wen G
Br J Radiol . 2024 Apr; 97(1158):1169-1179. PMID: 38688660
Objectives: This study aimed to develop a model to predict World Health Organization/International Society of Urological Pathology (WHO/ISUP) low-grade or high-grade clear cell renal cell carcinoma (ccRCC) using 3D multiphase...
9.
Toftdal M, Christensen N, Kadumudi F, Dolatshahi-Pirouz A, Grunnet L, Chen M
J Colloid Interface Sci . 2024 Apr; 667:54-63. PMID: 38615623
Type 1 diabetes mellitus (T1DM) is a chronic disease affecting millions worldwide. Insulin therapy is currently the golden standard for treating T1DM; however, it does not restore the normal glycaemic...
10.
Chen M, Li H, Zheng S, Shen J, Chen Y, Li Y, et al.
Phytomedicine . 2024 Mar; 128:155360. PMID: 38547624
Background: Autophagy could sense metabolic conditions and safeguard cells against nutrient deprivation, ultimately supporting the survival of cancer cells. Nobiletin (NOB) is a kind of bioactive component of the traditional...